Friday, May 06, 2016

Syntra-5 ,HSI HEALTH SCIENCES INSTITUTE MEMBERS ALERT FOR MAY 2009 Vol. 13, No. 11

HSI HEALTH SCIENCES INSTITUTE
MEMBERS ALERT FOR MAY 2009 Vol. 13, No. 11
Medical Adviser,Martin Milner,N.D.
Professor,National College of Natural Medicine;
President, Center for Natural Medicine, Portland,
OR;www.cnm-inc.com
Jon Barron
International lecturer, researcher, and author,
Los Angeles, CA
Eric Berg,D.C., C.R.A.
Founder, Health andWellness Center,
Alexandria,VA
Hyla Cass,M.D.
Orthomolecular physician and psychiatrist,
www.cassmd.com, LosAngeles, CA
Richard Cohan,D.D.S.,M.A.,M.B.A.
Professor, University of the Pacific School of
Dentistry, San Francisco, CA
Isaac Eliaz,M.D.,M.S., L.Ac.
Doctor and researcher specializing in integrative
medicine and cancer. Sebastopol, CA
M.M. Sree Ganesh,M.D.
Family practitioner, holistic and natural
medicine, Petaling Jaya,Malaysia
Ann Louise Gittleman, Ph.D., C.N.S.
Award-winning author, columnist, and media
personality,
www.annlouise.com, Hayden Lake, ID
Elson Haas,M.D.
Director, Preventive Medical Center of Marin,
www.elsonhaas.com, San Rafael, CA
Kohhei (Tadahiro)Makise,M.D.
Medical director, Kyoto Imadegawa Makise
Clinic, Kyoto, Japan
Claus D.Martin,M.D.
Founder, Four Seasons Medical Center and
Clinic, Rottach-Egern, Germany
Stephen Morrissey,O.M.D.
Founder, Center for Energetic Medicine and
Botanica Bioscience,Ojai, CA
Michael E. Rosenbaum,M.D.
Allergy, immunology, and clinical nutrition,
Corte Madera, CA
Al Sears,M.D.
Adjunct professor, Barry University,
West Palm Beach, FL
Robert Sinnott, Ph.D.
Biochemical technologies and research,
Phoenix, AZ
Allan Spreen,M.D.
Advisor on alternative medicine,Discovery
Channel, Phoenix, AZ
Leslie Taylor
Founder and president, Raintree Nutrition,
Carson City, NV
RandallWilkinson,M.D.
Board member, American Academy of
Environmental Medicine, Coeur d’Alene, ID
The opinions expressed here do not necessarily
reflect the views of every panelist eachmonth. The
Health Sciences Institute acknowledges occasional
differences of opinion among panelists and
welcomes the exchange of differing points of view.
HSI Advisory Panel
Hot-off-the-presses research reveals...
Blood sugar buster THREE TIMES
more effective than top-selling
diabetes drugs
by Melissa Hickle
Hot-off-the-presses research reveals…
Blood sugar buster THREE TIMES more
effective than top-selling diabetes drugs
Almost as soon as it was introduced, the success stories started
flooding in. Sugar levels were falling, pounds were plummeting, and
blood pressure was sinking. All thanks to a new herbal powerhouse
called Syntra-5.
But the word-of-mouth wasn’t enough for the scientists behind this
diabetes beater. So it was put to the test in a randomized, doubleblind,
placebo-controlled trial—the gold standard of scientific testing.
It turned out to be an all-out assault on diabetes. Fasting blood sugar
dropped a shocking 107 points. Triglycerides fell by an impressive
20%. LDL cholesterol tumbled by more than 34%. And total
cholesterol dropped over 29%.
If that weren’t enough, participants in the trial lost an average of
nearly 10 pounds—without changing eating or exercise habits.
And those were the results after only 90 days.
It all adds up to one undeniable fact—no other product,
pharmaceutical or natural, created to treat diabetes has been shown
to be even one half as effective as Syntra-5.
A formula so powerful, one company was
willing to lay it all on the line to prove it
It’s true. Even the top-selling diabetes drugs only drop blood glucose
levels by at most 36.6 points. That makes Syntra-5 three times more
effective—without the side effects of those drugs.
It’s hard to believe it took a major gamble to get this powerful
diabetes thrasher the attention it deserves. The story starts about 10
years ago,when Ken Hampshire, the co-founder of Syntratech, the
group that developed Syntra-5,met Dr.Vern Cherewatenko, the author
of The Diabetes Cure.
Dr. Cherewatenko had turned to Ken for help formulating and
manufacturing a new product for type 2 diabetes. Together, they
created Ultimate HCA, one of the first safe and effective solutions for
type 2 diabetes. 1
by Melissa Hickle
Members Alert • May 2009
Ken knew it was good, but he thought it could be even better. So
when, three years later,Dr. Cherewatenko turned his attention to
another project, Ken started scouring scientific journals.
In reviewing 20 years of research, he started seeing the same herbal
extracts come up again and again—extracts that were able to lower
insulin resistance in the body. Extracts that no other companies had
seemed to notice.
These extracts were expertly combined to become Syntra-5. When it
was introduced, the testimonials started pouring in. But for Ken, that
wasn’t enough. He wanted verifiable evidence that it was working.
Now, clinical trials are expensive. Too many companies with wonderful
products simply can’t afford to prove their effectiveness. So Ken
commissioned a small study to see how Syntra-5 fared. Though there
were only 17 participants, the results were very positive—so positive,
in fact, that Ken decided to lay it all on the line.
Syntratech is a small company. So it was a big deal when the team
there decided to put their entire marketing budget into a large-scale,
randomized, placebo-controlled human clinical trial conducted at an
independent lab. If Syntra-5 wasn’t proven effective, they would be
positively ruined.
But, as you already know—it worked. In fact, the results went beyond
even their greatest expectations.
Top-selling diabetes drugs just
can’t touch it
When it comes to fasting blood glucose, a level below 100 mg/dL is
considered normal or healthy and 100-125 mg/dL is considered
prediabetic (and brings with it increased risk of cardiovascular
disease). A count of 126 mg/dL,measured on two different days, is
indicative of diabetes.
And of course, that means big health risks. Damage to the eyes,
kidneys, blood vessels, heart, and nerves, as well as cognitive decline
and even dementia, are all linked to diabetes.
All of the participants in the trial had chronic uncontrolled blood
glucose,with fasting blood glucose counts between 160 mg/dL and
225 mg/dL.
Visit us online at www.HSIBaltimore.com 2 Members Alert • May 2009
In only 90 days, Syntra-5 brought those numbers down, on average, a
whopping 107 points. Every participant taking it saw his or her fasting
blood glucose drop to within the normal, healthy range.
If you’re watching your blood sugar levels, you’re also paying attention
to your two-hour glucose level. This should be below 140 mg/dL. A
count between 140 and 200 mg/dL indicates impaired glucose
tolerance, and a level over 200 mg/dL goes hand in hand with
diabetes.
Over the course of the trial, participants taking Syntra-5 experienced a
54.55% decrease in two hour glucose levels. For participants taking
the placebo, the level rose an average of just over 4%.
A third test measures the average amount of glucose in the blood
over the 2-3 months prior to the test. It does this by measuring the
concentration of hemoglobin A1c, or glycated hemoglobin. A 1%
change in A1c reflects a change of about 30 mg/dL in average blood
glucose level.
When blood was drawn from participants taking Syntra-5 at the end
of the trial, A1c levels had dropped from an average concentration of
7.7% to an average of 4.66%—a highly significant 3% drop. All of the
subjects in the active group had their A1c levels drop to 5% or below.
Now, Syntra-5’s effect on blood glucose levels would be impressive on
its own. But this herbal formula had more in store for the trial
participants. Triglycerides, a type of fat within the bloodstream,
decreased an average of over 20% in participants taking Diaxtroxal.
With placebo, there was an average increase of 6.6%. Cholesterol
levels were also positively affected by Syntra-5. In the active group,
participants’ LDL cholesterol was lowered by over 34%, and their total
cholesterol went down by 29%.
Syntra-5 demonstrated action on blood pressure as well. Over the
course of the 90 days, participants taking Syntra-5 were rewarded with
an average 25% drop in systolic pressure, 5% diastolic.
Then there was the weight loss. Prior to the trial,most of the
participants had already been trying to control their blood sugar
levels with diet and exercise. But they weren’t having much luck. The
researchers conducting the trial told the participants not to make any
changes in diet, exercise or water intake.
Visit us online at www.HSIBaltimore.com 3 Members Alert • May 2009
Even without making such changes, the participants in the Syntra-5
group lost an average of almost 10 pounds. They expressed no
changes in hunger or appetite, and no changes in cravings for sweets.
Of course, all of these numbers are meaningful. But they become even
more important when paired with how the participants felt during the
course of the trial.
Only two weeks in, 25% of the people in the active group said they felt
better than they had in years. After one month, half of them reported
having more energy.
Of course, the overall result of the test, reported by the researchers,
was that Syntra-5 is a very safe and effective product for the
management of diabetes.1
When the results of the study went through the peer-review process, it
was noted that Syntra-5 beat the heck out of the leading diabetes
drugs.
The seven leading pharmaceutical drugs for diabetes lower A1c less
than 1%, and none of them are able to lower it to a level below 7%.
Put simply, Syntra-5 produced more than a three-fold greater decrease
in A1c than pharmaceuticals.
And when it comes to fasting blood glucose, pharmaceutical products
can’t touch Syntra-5. The most fasting blood glucose drops with the
top-selling diabetes drugs is 36.6 mg/dL. In the Syntra-5 trial, the
average was an amazing 107 points. This great an effect was
previously unheard of.2
20 years’worth of research boiled down
into one breakthrough blend
When I talked to Ken, I asked him to tell me what he considered the
“super stars” among the herbal extracts that make up Syntra-5. He
didn’t have to think long.
Back when he was scouring 20 years’worth of research, he saw two
substances come up more than any others.
Hydroxycitric acid (HCA) and Gymnema sylvestre extract work in a
number of ways to improve glucose metabolism. While there are
quite a few studies on these components, two provide a good
example of their effect.
Visit us online at www.HSIBaltimore.com 4 Members Alert • May 2009
In a 2004 animal study conducted at Georgetown University, HCA was
found effective and safe as a weight-loss agent. It was also shown to
inhibit the enzyme that controls the synthesis of fatty acids,
cholesterol, and triglycerides. The effects were dramatic after a period
of only eight weeks.3
In another study (also conducted at Georgetown) combining HCA
with chromium (which is also in Syntra-5) and gymnema sylvestre
extract, total cholesterol was lowered 9.5% and LDL cholesterol was
lowered 19%,while HDL cholesterol went up by 22.1%. Triglyercides
dropped by 20.5%.4
These two ingredients are joined by ten other active ingredients, all
painstakingly researched by Ken. And what he didn’t include is almost
as important.
In many popular natural products used to treat diabetes, you’ll see the
same ingredients pop up over and over. Ingredients like alpha lipoic
acid and CoQ-10 were not included in Syntra-5 because Ken just
wasn’t seeing the evidence that they work. Rather than following the
trend set by other companies, he has created a completely new
formula. And the evidence speaks for itself.
Drop blood sugar, pounds, and
blood pressure in one easy step
A while ago, I mentioned that when Syntra-5 was introduced, the
testimonials started pouring in. Well, they haven’t stopped. I was
given pages and pages of them, and promised more if I needed them.
I’ll share just a few.
Charles in Arizona didn’t want to take drugs to control his blood sugar,
so he went in search of a natural option. An Internet search led him to
Syntra-5, and he decided to take a chance. After just a couple of
weeks, his energy returned and he had started losing weight.
His blood sugar had started in the high 300s, but plunged to the high
90s. He says he’s very satisfied, but jokes that “the drug companies are
probably not happy with Syntra-5 because their bank accounts are
smaller.”
Lynn in New Mexico wanted another option when her doctor
presented her with a month’s supply of Avandia. She never even
broke the seal—instead, she found Syntra-5.
Visit us online at www.HSIBaltimore.com 5 Members Alert • May 2009
Just over three months later, she had dropped 20 pounds and four
inches in her waist. Her blood sugar had gone down from 182 to 111.
At her last checkup, her blood pressure was 110/80. Her doctor was
amazed, and told her to just keep on doing what she’d been doing.
Mike in Minnesota has also been singing the praises of Syntra-5. His
blood sugar has gone from 180 to under 120 and he’s feeling a lot
more energetic these days. He unexpectedly lost 10 pounds and
“would highly recommend this product to anyone.”
Syntra-5, Syntratech Corporation. Ph (800)738-0650;www.Syntra5.com. A
one-month supply (180 count bottle) is US$59.95. Buy two, get one bottle
free US$119.90. Flat shipping fee of US$9.95 on all domestic orders, US$29.95
international.
Please note: HSI receives no compensation for providing editorial coverage
for the products that appear in your Members Alert. HSI is a subsidiary of the
same holding company as NDI Solutions, the distributor of NorthStar
Nutritionals, Real-Advantage and Pure Country Naturals supplements.
HSI verifies all product information when the Members Alert is written;
however, pricing and availability can change by the time the issue is
delivered. We regret that not all products are available in all locations
worldwide.
The above statements have not been evaluated by the U.S. Food and Drug
Administration. These products are not intended to diagnose, treat, cure, or
prevent any disease.
Our Mission
The Health Sciences Institute is dedicated to uncovering and researching the
most urgent advances in modern underground medicine.
Whether they come from a laboratory in Malaysia, a clinic in South America,
or a university in Germany, our goal is to bring the treatments that work
directly to the people who need them. We alert our members to exciting
breakthroughs in medicine, show them exactly where to go to learn more,
and help them understand how they and their families can benefit from
these powerful discoveries.
Visit us online at www.HSIBaltimore.com 6 Members Alert • May 2009
Citations available upon request and on HSI website
To contact the Health Sciences Institute members services hotline, please call
(915)849-4614, fax to (410)230-1273, or write to Health Sciences Institute, 702
Cathedral St., Baltimore,MD 21201. All cancellations should be mailed to P.O.
Box 206, Baltimore,MD 21203. You may also contact a member services
specialist via e-mail at service@HealthierNews.com.
Your private Members Alert is a monthly publication of the Health Sciences
Institute. ©Copyright 2009 Institute for Health Sciences L.L.C., 702 Cathedral
St., Baltimore,MD 21201. Published monthly for $74 per year ($6.16 an issue).
POSTMASTER: Send address changes to Health Sciences Institute, 702
Cathedral St., Baltimore,MD 21201. All rights reserved. No part of this report
may be reproduced by any means or for any reason without the consent of
the publisher.
This information is provided as information only and may not be construed as
medical advice or instruction. No action should be taken based solely on the
contents of this publication. Readers should consult appropriate health
professionals on any matter relating to their health and well-being. The
information and opinions provided in this publication are believed to be
accurate and sound, based on the best judgment available to the authors, but
readers who fail to consult appropriate health authorities assume the risk of
any injuries. The publisher is not responsible for errors or omissions.
Used with permission by Health Sciences Institute.
7
Director
Jenny Thompson
Associate Director
Paul Amos
Managing Editor
Melissa Hickle
Copy Editor
Ken Danz
Designer
GerritWessendorf
Member Services
Jeffrey Byers
Visit us online at www.HSIBaltimore.com Members Alert • May 2009

No comments: